NCT02528552Unknown2 期
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 80
- 试验地点
- 8
- 主要终点
- Hair growth
研究概览
简要总结
This is a prospective, randomized double-blind, multi-center study to evaluate the efficacy of low level laser therapy over-the-counter at home device Theradome LH80 PRO, compared to SHAM for promoting hair growth in males diagnosed with androgenetic alopecia, and a usability study to assess subject ability to self-assess hair loss and understanding use of the device.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Subject must be diagnosed with androgenetic alopecia with Norwood Hamilton hair loss scale of IIa, III vertex, IV and V.
- •Subject must have Fitzpatrick skin type scale I to IV.
- •Subject must be able to visit clinic site for baseline, 13 week and 26 week study visits and attend 2 visits by phone ( 6 and 19).
- •Hair must be at least 1 inch in length. The hairstyle and length shall be the same for each site visit. Subjects are instructed to have their hair cut/styled 1-5 days in advance of a site visit.
- •Be willing to undergo all study procedures including consent for global photographs of hair loss/growth and a 1 mm tattoo to mark the macrophotography site along the indicated transition area of the scalp between the hairline and the balding area of the vertex.
- •Be willing to avoid use of wigs, hairpieces, and/or hair extensions during the study period.
- •Ability to communicate effectively with study personnel.
- •Agrees to abstain from use of any hair growth affecting oral or topical medication including over the counter and herbal medications, minoxidil, finasteride or dutasteride during the course of this study
排除标准
- •History of taking Propecia or any other hair growth supplements for 12 months prior to enrollment.
- •History of using Rogaine for 6 months prior to enrollment.
- •Subject must have no previous hair transplant, cell treatment, micro needling, or any other treatment in the last 6 months in the scalp.
- •Subject is currently suffering from an active autoimmune disease such as serum lupus erythematosus, or alopecia areata.
- •Currently suffering from dermatologic condition in the treatment area or has a significant scar in the hair treatment area that, in the opinion of the investigator, will make hair growth difficult (such as systemic burns, etc).
- •Subject has a sensitivity or allergy to tattoo ink.
- •Clinically significant medical or psychiatric illness currently or within 30 days of study screening as determined by the investigator.
- •Employed by sponsor, clinic site, or entity associated with the conduct of the study.
结局指标
主要结局
Hair growth
时间窗: 26 weeks
Determination of hair growth vs baseline through global photographic review by a blinded reviewer(s).
Quantitative Hair Growth
时间窗: 26 weeks
Change from baseline in non-vellus Terminal Hair count (≥ 30 μm) as measured with macrophotography (aka trichogram).
次要结局
- Subject Self Assessment(26 weeks)
研究者
研究点 (8)
Loading locations...
相似试验
Unknown
不适用
Scaphoid Non-union and Low-intensity Pulsed Ultrasound TrialNonunion of Fracture of Scaphoid BoneFractures, UnunitedNCT02383160University of Calgary154
Unknown
不适用
Trial of Long-term Therapeutic Hypothermia for Poor-grade Aneurysmal Subarachnoid HemorrhageAneurysmal Subarachnoid HemorrhageHypothermiaNCT03442608Xuanwu Hospital, Beijing200
暂停
不适用
Study to Evaluate the Safety and Efficacy of PEER Interactive Versus Treatment as Usual in Subjects With a Primary Diagnosis of DepressionDepressive DisorderNCT01794559MYnd Analytics1,922
已完成
2 期
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular DystrophyDuchenne Muscular DystrophyNCT03039686Hoffmann-La Roche166
进行中（未招募）
不适用
Treatment of Knee Osteoarthritis With PAAG-OAOsteoarthritis, KneeNCT04045431Contura238